News & Events

Philogen S.p.A announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach. Siena, 21st January 2016.

2_1_Press Release Philogen_Phase III_Melanoma_final

Last News & Events

No Results Found

The posts you requested could not be found. Try changing your module settings or create some new posts.